ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancerMin Ho Choe, Jae‐Sung Kim|Oncotarget|2015Cited by 72
miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAPMin Ho Choe, Jae‐Sung Kim|Cell Death and Disease|2018Cited by 40
MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cellsYi Na Yoon, Jae‐Sung Kim|BMC Cancer|2018Cited by 40
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast CancerAh Young Kim, Jae‐Sung Kim|Frontiers in Oncology|2020Cited by 24
Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3Jae‐Sung Kim, Chul‐Su Yang|Cellular and Molecular Immunology|2023Cited by 22